港股详情

本页面由TTMF Limited提供服务

剂泰科技-P待上市

10.500

0.000

成交量：- -

成交额：- -

市值：121.01亿

市盈率：- -

高：10.500

开：10.500

低：10.500

收：10.500

52周最高：10.500

52周最低：10.500

股本：11.53亿

香港流通股本：10.53亿

量比：- -

换手率：- -

股息：- -

股息率：- -

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

市销率: - -

1

开始申购

05/05

2

申购截止

05/08 10:15

3

公布中签

05/11

4

暗盘

05/12 16:15 - 18:30

5

挂牌上市

05/13

总览公司新闻资讯公告

公司资料

公司名字：

剂泰科技-P

交易所：

SEHK

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

http://www.metistechbio.com/

邮编：

- -

电话：

- -

传真：

- -

简介：

AI纳米递送,开启健康未来。剂泰科技是一家人工智能(AI)驱动纳米材料创新的生物科技公司,专注于利用靶向药物递送和发现技术,加速患者在重要疾病领域获得创新疗法。公司由美国工程院院士陈红敏博士以及MIT科学家赖才达博士、王文首博士联合创立,成功自主开发了AI纳米基座大模型及三大核心解决方案:AiLNP(AI纳米递送系统设计平台)、AiRNA(AI mRNA序列设计平台)、AiTEM(AI小分子制剂设计平台)。公司已具备实现肝脏、肺部、肌肉和免疫细胞等关键组织和细胞的LNP精准靶向递送能力,在多器官、多组织靶向递送难题上取得突破性进展,为肿瘤、代谢系统疾病、自体免疫性疾病、神经系统退行性疾病等提供成药机会。

董事

名称

职位

赖才达

董事会主席，执行董事，薪酬与考核委员会委员

Hongming Chen

执行董事，提名委员会委员

王文首

执行董事

林怡仲

独立非执行董事，薪酬与考核委员会委员，审计委员会主席

李晋

独立非执行董事，薪酬与考核委员会主席，提名委员会委员，审计委员会委员

Peter Edward Lobie

独立非执行董事，提名委员会主席，审计委员会委员

黄瀚涛

非执行董事

公元

非执行董事

股东

名称

职位

赖才达

首席执行官

付翀

首席财务官，董事会秘书，联席公司秘书

王文首

首席运营官

李亮贤

联席公司秘书

Mark Robert Herbert

首席商务官

徐伟

首席科学官

Hongming Chen

首席研发官

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/07666/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"07666","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"07666\",,,,,undefined,":{"symbol":"07666","market":"HK","secType":"STK","nameCN":"剂泰科技-P","latestPrice":10.5,"timestamp":1778054400000,"preClose":10.5,"halted":9,"volume":0,"delay":0,"changeRate":0,"floatShares":1052926111,"shares":1152513850,"eps":0,"marketStatus":"待上市","change":0,"latestTime":"05-06 16:00:00","open":10.5,"high":10.5,"low":10.5,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1778635800000},"marketStatusCode":8,"adr":0,"listingDate":1778601600000,"exchange":"SEHK","adjPreClose":10.5,"openAndCloseTimeList":[[1778031000000,1778040000000],[1778043600000,1778054400000]],"volumeRatio":0,"ipoDetail":{"name":"剂泰科技－Ｐ","exchange":"SEHK","listingDate":"2026-05-13","sharesOutstanding":1152513850,"sharesFloat":1152513850,"offerAmount":201229000,"priceRange":"10.500","market":"HK","openProspectusDate":"2026-05-05","openProspectusUrl":"https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0505/2026050500020_c.pdf","purchaseBeginDate":"2026-05-05","purchaseEndDate":"2026-05-08","winningDate":"2026-05-12","currency":"HKD","minPurchaseQuantity":500,"peRate":-27.94,"use":"1、约988.5百万港元（约50.0%）将用于支撑公司的人工智能基础设施及人工智能驱动纳米材料平台的核心技术研究、开发及推进；\n2、约395.4百万港元（约20.0%）将用于公司人工智能开发产品管线中正在进行及计划开展的临床试验；\n3、约197.7百万港元（约10.0%）将用于开发公司的动物健康及抗衰解决方案，并将人工智能赋能的解决方案拓展至该等高增长领域；\n4、约197.7百万港元（约10.0%）将分配用于支持公司在全球构建人工智能驱动纳米材料生态系统的增长战略；\n5、约197.7百万港元（约10.0%）将用作营运资金及其他一般企业用途。","industryId":"204005","industryName":"医疗保健","business":"公司是人工智能纳米材料创新的领军者，致力于有效载荷（Payload）在所有生命形态中的递送与应用，秉承以AI纳米创新开启健康未来。NanoForge是公司专有的、协同整合的人工智能驱动纳米科技创新体系的基础，涵盖公司自主生成的庞大脂质库、人工智能基础模型、METiS智能体、量子化学与分子动力学模拟及人工智能驱动的高通量筛选平台。在此基础上，公司开发了三大专业的解决方案（即AiTEM、AiLNP及AiRNA平台），用以模拟、预测及阐释纳米级别的相互作用关系，从而实现对先进纳米材料及其相关有效载荷的合理设计、优化及验证。","subscribed":513.9,"marketCap":12101000000,"minimumCapital":5302.95,"overAllotment":true,"lotSize":500,"issueOpenRate":0.05,"subscribeGear":"500,1000,1500,2000,2500,3000,3500,4000,4500,5000,6000,7000,8000,9000,10000,15000,20000,25000,30000,35000,40000,45000,50000,60000,70000,80000,90000,100000,200000,300000,400000,500000,1000000,1500000,2000000,2500000,3000000,3500000,4000000,5030500","issueRatio":0.05,"offeringMechanism":"18C"},"greyMarketDetail":{"greyDate":"2026-05-12","greyDateTimestamp":1778515200000,"greyOpeningTime":1778573700000,"greyClosingTime":1778581800000,"showGreyQuote":false,"openProspectusDate":"2026-05-05","listingDate":"2026-05-13"},"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"07666\",,,,,undefined,":{"symbol":"07666","floatShares":1052926111,"roa":"--","roe":"--","lyrEps":0,"shares":1152513850,"dividePrice":0,"high":10.5,"amplitude":0,"preClose":10.5,"low":10.5,"week52Low":10.5,"pbRate":"--","week52High":10.5,"institutionHeld":0,"latestPrice":10.5,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":10.5},"@#url:\"https://hktrade.skytigris.com/ipos/general/07666\",,undefined,":{"id":9973,"type":"COMMON","ipoName":"07666-IPO","symbol":"07666","companyName":"剂泰科技-P","market":"HK","currency":"HKD","status":"OPEN","underwriter":"富瑞金融集团香港有限公司","lotSize":500,"minQty":500,"expectedOfferingSize":201229000,"openingDate":1777944600000,"closingDate":1778206500000,"commonClosingDate":1778206500000,"allotmentDate":1778428800000,"listDate":1778601600000,"marginable":true,"marginRate":10,"latestPrice":10.5,"minPrice":10.5,"maxPrice":10.5,"prospectusUrl":"https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0505/2026050500020_c.pdf","allowedQuantities":[500,1000,1500,2000,2500,3000,3500,4000,4500,5000,6000,7000,8000,9000,10000,15000,20000,25000,30000,35000,40000,45000,50000,60000,70000,80000,90000,100000,200000,300000,400000,500000,1000000,1500000,2000000,2500000,3000000,3500000,4000000,5030500],"interestRate":0,"recommend":false,"isHint":false,"interestStartDate":1778169600000,"interestEndDate":1778342400000,"delayAllocate":false,"isSupportGreyMarket":true,"greyMarketTradeDate":1778573700000,"transactionRate":0.010085,"gstFeeRate":0,"rank":0,"subscribed":false,"signed":false,"financingInfos":[{"ipoName":"07666-IPO","ipoId":9973,"financingId":59540,"type":1,"availableFundLimit":5302.94,"piAvailableAmountLimit":0,"piMaxAvailableAmountLimit":-1,"piMinSubscribeAmount":0,"piMaxSubscribeAmount":-1,"minSubscribeLimit":53029.4,"maxSubscribeLimit":-1,"marginRate":10,"interestRate":0,"openTime":1777944600000,"closeTime":1778206500000,"isAtValidTime":true,"subscriptionMethod":"FINANCING","processFee":0,"supportPI":false,"applyFundLimit":5302.94,"threshold":50000000000,"isAvailable":false},{"ipoName":"07666-IPO","ipoId":9973,"financingId":59533,"type":4,"availableFundLimit":5302.94,"piAvailableAmountLimit":0,"piMaxAvailableAmountLimit":-1,"piMinSubscribeAmount":0,"piMaxSubscribeAmount":-1,"minSubscribeLimit":0,"maxSubscribeLimit":-1,"marginRate":100,"interestRate":0,"openTime":1777944600000,"closeTime":1778206500000,"isAtValidTime":true,"subscriptionMethod":"CASH","processFee":0,"supportPI":false,"applyFundLimit":5302.94,"threshold":50000000000,"isAvailable":false}],"financingNotifyEnabled":false,"financingNotifySubscribed":false,"subscriptionMethods":[{"method":"CASH","closeTime":1778206500000,"available":false,"messageCode":"AVAILABLE_FUND_LIMIT","minAvailableFundLimit":5302.94},{"method":"FINANCING","closeTime":1778206500000,"available":false,"messageCode":"AVAILABLE_FUND_LIMIT","minAvailableFundLimit":5302.94}],"latestClosingDate":1778206500000,"subscribedFinanceRatio":513.9,"subscribedRatio":513.9,"forecastRatio":668.07,"raiseMoney":105650000,"totalMargin":54291520000,"quoteInfoUpdatedAt":1778105769112,"forecastMarketValue":12101395425,"minForecastMarketValue":12101395425,"maxForecastMarketValue":12101395425,"sharesOutstanding":1152513850,"business":"公司是人工智能纳米材料创新的领军者，致力于有效载荷（Payload）在所有生命形态中的递送与应用，秉承以AI纳米创新开启健康未来。NanoForge是公司专有的、协同整合的人工智能驱动纳米科技创新体系的基础，涵盖公司自主生成的庞大脂质库、人工智能基础模型、METiS智能体、量子化学与分子动力学模拟及人工智能驱动的高通量筛选平台。在此基础上，公司开发了三大专业的解决方案（即AiTEM、AiLNP及AiRNA平台），用以模拟、预测及阐释纳米级别的相互作用关系，从而实现对先进纳米材料及其相关有效载荷的合理设计、优化及验证。","greyOpeningTime":1778573700000,"greyClosingTime":1778581800000,"tradable":true,"showClawback":true,"clawbackType":"18C规则","clawbackRate":5},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.metistechbio.com/","compareEarnings":[{"period":"1week","weight":0.0039},{"period":"1month","weight":0.0437},{"period":"3month","weight":-0.025},{"period":"6month","weight":-0.0011},{"period":"1year","weight":0.1567},{"period":"ytd","weight":0.0228}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"AI纳米递送,开启健康未来。剂泰科技是一家人工智能(AI)驱动纳米材料创新的生物科技公司,专注于利用靶向药物递送和发现技术,加速患者在重要疾病领域获得创新疗法。\n公司由美国工程院院士陈红敏博士以及MIT科学家赖才达博士、王文首博士联合创立,成功自主开发了AI纳米基座大模型及三大核心解决方案:AiLNP(AI纳米递送系统设计平台)、AiRNA(AI mRNA序列设计平台)、AiTEM(AI小分子制剂设计平台)。\n公司已具备实现肝脏、肺部、肌肉和免疫细胞等关键组织和细胞的LNP精准靶向递送能力,在多器官、多组织靶向递送难题上取得突破性进展,为肿瘤、代谢系统疾病、自体免疫性疾病、神经系统退行性疾病等提供成药机会。","exchange":"SEHK","name":"剂泰科技-P","nameEN":"METIS TECHBIO-P"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"07666\",market:\"HK\",,,undefined,":{"directors":[{"name":"赖才达","position":"董事会主席，执行董事，薪酬与考核委员会委员"},{"name":"Hongming Chen","position":"执行董事，提名委员会委员"},{"name":"王文首","position":"执行董事"},{"name":"林怡仲","position":"独立非执行董事，薪酬与考核委员会委员，审计委员会主席"},{"name":"李晋","position":"独立非执行董事，薪酬与考核委员会主席，提名委员会委员，审计委员会委员"},{"name":"Peter Edward Lobie","position":"独立非执行董事，提名委员会主席，审计委员会委员"},{"name":"黄瀚涛","position":"非执行董事"},{"name":"公元","position":"非执行董事"}],"executives":[{"name":"赖才达","position":"首席执行官"},{"name":"付翀","position":"首席财务官，董事会秘书，联席公司秘书"},{"name":"王文首","position":"首席运营官"},{"name":"李亮贤","position":"联席公司秘书"},{"name":"Mark Robert Herbert","position":"首席商务官"},{"name":"徐伟","position":"首席科学官"},{"name":"Hongming Chen","position":"首席研发官"}]}}}